The results from previous studies correlating CF disease severity with CFTR-mediated Cl− secretion in nasal and rectal epithelia predict that functional correction to this level (i.e. ∼20%) may ameliorate disease severity, but will be insufficient to prevent CF organ disease [16], [17]. This evidence concerns the gene CFTR and glycogen storage disease VI.